Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BeiGene
Biotech
AbbVie sues BeiGene over blood cancer drug trade secrets
After scoring an FDA Fast Track tag for its BTK degrader candidate, BeiGene has been accused of trade secrets theft by its old oncology rival AbbVie.
Fraiser Kansteiner
Sep 11, 2024 10:17am
BeiGene offers up $1.3B in biobucks for preclinical cancer drug
Nov 21, 2023 7:13am
Novartis retreats from TIGIT, handing $300M drug back to BeiGene
Jul 11, 2023 9:20am
BeiGene bags option on DualityBio ADC in backloaded $1.3B deal
Jul 10, 2023 9:00am
Ex-J&J research chief lands at FogPharma—Chutes & Ladders
Mar 31, 2023 9:30am
BeiGene lets option on Leap’s immuno-oncology candidate lapse
Mar 17, 2023 8:50am
